Lei Chen, PhD presents Rarity SafeLock at The Global Engage Conference, London, December 7

Co-founder of Rarity Bioscience, Lei Chen, PhD presents Rarity SafeLock, our ultra sensitive targeted mutation detection approach that outperforms ddPCR sensitivity using flow cytometry readout. The presentation includes clinical data from AML patients including mutation-prone high-GC regions. THE RESEARCH & TECHNOLOGY SERIES: qPCR & DIGITAL PCR / LIQUID BIOPSIES / FLOW CYTOMETRY Not attending this…